Lindus Health Awarded Funding From ARIA to Build Safe and Reliable AI for Clinical Trial Design
Summary
Todays AI systems, while powerful, lack the reliability needed for high-stakes applications such as clinical trial design, where hallucinations or biased decision-making could lead to undesirable outcomes. The project aims to develop a solution that leverages mathematical proofing techniques to recommend best practices to clinical trial researchers while delivering verifiable safety guarantees. The innovation promises to substantially reduce trial setup times, lower costs, and increase accuracyultimately accelerating the development of life-saving therapies while building much-needed trust in AI tools among clinical researchers who have been reluctant to adopt them. This is achieved through a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), a world-class clinical operations team with its unique software platform, and access to over 40 million Electronic Health Records.Clinical trials are the biggest bottleneck to advances in healthcare. The company has raised over $80M from investors including Peter Thiel, Balderton, Creandum, Firstminute Capital, and Seedcamp.ARIA is the UKs specialized R&D funding agency built to unlock scientific and technological breakthroughs that benefit everyone.